Jennifer Terrell, NP
Nurse Practitioner · Billings, MTNPI 1386206936
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,062 of the $6,528 with a category attached, or 62.2%. 17 manufacturers reported payments, led by Medtronic at 34.4% of the total. Reporting peaked in 2023 at $4,053 and has fallen 99.6% since, to $17 in 2025. Among nurse practitioner clinicians in MT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 127 payments — averaging $51.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- AbbVie$2K
- Nevro Corp.$1K
- Amgen$420
- Merz Pharmaceuticals, LLC$262
- Teva Pharmaceuticals USA, Inc.$194
- plus $443 from 11 others
What the payments were for
- Speaking & faculty fees$2704%
- Travel & lodging$2,05732%
- Food & beverage$4,06262%
- Education$1392%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 18 | $2,245 |
| AbbVie(2 entities) | 54 | $1,624 |
| Nevro Corp. | 12 | $1,340 |
| Amgen | 9 | $420 |
| Merz Pharmaceuticals, LLC | 10 | $262 |
| Teva Pharmaceuticals USA, Inc. | 9 | $194 |
| Biodelivery Sciences International, Inc. | 1 | $76 |
| Redhill Biopharma Inc. | 1 | $71 |
| Lundbeck LLC | 2 | $51 |
| Pfizer | 3 | $45 |
| Emergent Biosolutions Inc. | 1 | $45 |
| GRT US Holding, Inc. | 1 | $45 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $39 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
| Baudax Bio Inc. | 1 | $19 |
| Biohaven Pharmaceuticals, Inc. | 1 | $17 |
| Merck | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,528 in reported general payments places this provider in the 95th percentile of 357 nurse practitioner providers in Montana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aimovig AutoinjectorErenumab-Aooe | 37 | $30,984 |
| UbrelvyUbrogepant | 13 | $15,894 |
| Emgality PenGalcanezumab-Gnlm | 17 | $12,928 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 58 | $2,169 |
| Oxycodone Hcl | 58 | $864 |
| Topiramate | 45 | $858 |
| Sumatriptan Succinate | 43 | $609 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 20 | $461 |
| Morphine Sulfate | 16 | $449 |
| Gabapentin | 33 | $429 |
| Morphine Sulfate ErMorphine Sulfate | 16 | $346 |
| RizatriptanRizatriptan Benzoate | 22 | $317 |
| Tizanidine Hcl | 18 | $302 |
| Hydromorphone Hcl | 22 | $294 |
| Amitriptyline Hcl | 31 | $225 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieUbrelvy | $1,624 | $15,89413 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 357 nurse practitioner providers in Montana.
Other nurse practitioner in Billings
- Amanda Abrams-BuerkleyBillings$6K
- Andrea LappBillings$4K
- Lisa PrincipeBillings$2K
- Marcus NicolaBillings$2K
- Amelia ClarkBillings$1K
- Jodi GilliganBillings$700
- Mary BrownBillings$680
- Melissa FullerBillings$630
- Kristen BeckBillings$595
- Lindsay CantwellBillings$584
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.